<DOC>
	<DOCNO>NCT00225732</DOCNO>
	<brief_summary>The primary objective study Caldolor ( IV ibuprofen ) administer post-operative hospitalized adult patient every 6 hour 48 hour determine efficacy Caldolor compare placebo treatment post-operative pain measure reduction requirement narcotic analgesic , morphine , post surgery</brief_summary>
	<brief_title>Trial Caldolor Treatment Pain Post-Operative Adult Patients</brief_title>
	<detailed_description />
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>1 . Scheduled elective abdominal hysterectomy surgery anticipate need postoperative I.V . morphine analgesia anticipate use ≥ 24 hour . 2 . Adequate IV access 3 . Anticipated hospital stay ≥ 24 hour 1 . Be unable make reliable selfreport pain intensity pain relief 2 . Less 18 year age 3 . Greater 70 year age 4 . Use NSAIDs within 12 hour prior dose 5 . Use analgesic , muscle relaxant sedatives less 24 hour prior CTM administration follow exception : paracetamol ( acetaminophen ) administer 6 hour prior surgery ; tramadol administer midnight even prior surgery ; muscle relaxant work neuromuscular junction use intubation and/or anesthesia administration surgical procedure prior CTM administration ; sedative ( i.e. , midazolam ) use coinduction agent surgical procedure prior CTM administration 6 . Patients take warfarin , lithium , combination ACEinhibitors furosemide 7 . Patients anemia ( active clinically significant ) and/or history evidence asthma heart failure 8 . History allergy hypersensitivity component Caldolor , aspirin ( aspirin relate product ) , NSAIDs , COX2 inhibitors 9 . Pregnant nursing 10 . History severe head trauma require current hospitalization , intracranial surgery stroke within previous 30 day , history intracerebral arteriovenous malformation , cerebral aneurysm CNS mass lesion 11 . Weigh less 30kg 12 . Have history congenital bleeding diathesis ( eg hemophilia ) active clinically significant bleeding , underlie platelet dysfunction include ( limited ) idiopathic thrombocytopenic purpura , disseminate intravascular coagulation , congenital platelet dysfunction 13 . Have GI bleeding require medical intervention within previous 6 week ( unless definitive surgery perform ) 14 . Have platelet count le 30,000mm3 determine within 28 day prior surgery 15 . Preexisting dependence narcotic know tolerance opioids 16 . Inability understand requirement study , willing provide write informed consent ( evidenced signature inform consent document approve Institutional Review Board [ IRB ] ) , agree abide study restriction return require assessment 17 . Refusal provide write authorization use disclosure protect health information 18 . Be dialysis , oliguria calculate creatinine clearance le 60 mL/min ( calculate use Cockcroft Gault formula ) determine within 28 day prior surgery 19 . Inability achieve hemostasis inability close surgical incision , prior Operating Room discharge 20 . Operative procedure include organ transplant 21 . Pre intraoperative procedure utilized prevention pre postoperative pain ( i.e . epidural nerve block ) 22 . Be receive full dose anticoagulation therapy Activated Protein C within 6 hour dose ( Prophylaxis subcutaneous heparin acceptable ) 23 . Have receive another investigational drug within past 30 day 24 . Be otherwise unsuitable study opinion investigator</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>